A 53-year-old working professional battling dystonia has been successfully treated with advanced lesioning surgery in Mumbai. The surgery promises to offer renewed hope to him and other patients with ...

In 2017 he visited his GP and was diagnosed with Parkinson's. He was told there were medicines but no cure, but there was a ...

Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of ...

New research reveals a significant reduction in Parkinson’s disease risk among autoimmune patients treated with anti-TNF or ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Scientific research and experts say the very common problem suffered by millions can be an early sign of Alzheimer's ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

As a young physiology student Tipu Aziz was inspired by watching grainy videos from the 1970s showing patients undergoing ...

2,058 patients are benefiting from Parkinson’s medication and 149 are receiving treatment for the rare condition of ...

GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...